F

Fei Ma

Chinese Academy of Medical Sciences & Peking Union Medical College

ORCID: 0000-0001-9432-1902

Publishes on Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies. 731 papers and 10.2k citations.

PubIndex Score85Top 15% · seniorHow it's scored

731Publications

10.2kTotal Citations

First publication: 1988First senior author: 2002

Breast Cancer Treatment Studies Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations

Top publicationsby citations

MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1

Fei Ma, Xiaohui Qiu|Oncotarget|2015

Cited by 96

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

Fei Ma, Binghe Xu, Min Yan et al.|BMJ|2023

Cited by 82

Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer

Zongbi Yi, Fei Ma, Jin Li et al.|npj Breast Cancer|2020

Cited by 74

Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and Global Burden of Disease Study

Lixi Li, Fei Ma, Tianhao Shan et al.|Journal of the National Cancer Center|2024

Cited by 72

S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancer

Hongnan Mo, Fei Ma, Xuefeng Liu et al.|Molecular Cancer|2022

Cited by 57